UPyTher’s mission is to provide custom drug delivery solutions that enable sustained localized administration of therapeutics.

By exploiting human organoids, VEO enhances the predictive value of antiviral testing over the current pre-clinical models.

Vital Wear develops sensor textiles that measure pressure and temperature to prevent pressure ulcers, providing better support for patients and caregivers.

VivArt-X develops synthetic support material for specific cell therapies. Our lead indication will revolutionize breast reconstructive surgery in women who have undergone breast tissue removal after breast cancer diagnosis.

Voyagen is a pharmatech startup pioneering the discovery of transcription factors as next-generation targets for oncology, with a focus on gastrointestinal tumors where current therapies are ineffective.

Validated physiological stress monitoring technology that supports objective decision-making in burnout recovery and occupational health.

The ambition of X-Heal Diagnostics is to improve lung health through fast, specific and non-invasive diagnosis of lung infections in different patient groups including chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) and tuberculosis patients.

Our revolutionary and novel device connects the artery and vein only during dialysis. At all other times it is closed, and normal circulation is restored. Our device, the Dynamic AVF will set the new gold standard for haemodialysis.

YourRhythmics develops a medical device that generates a standard ECG, esophageal ECG and reduced BSPM.

Kingfisher has developed a mechanical device that improves the precise placement of heart stents, reducing risks and costs during coronary interventions.